Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas (original) (raw)

• Zbar, B. et al. Hereditary papillary renal carcinoma. J. Urol. 151, 561–566, (1994).
  Article CAS Google Scholar
• Zbar, B. et al. Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J. Urol. 153, 907–912 (1995).
  Article CAS Google Scholar
• Bernades, P. et al. Cancer du rein gauche chez trois membres d'une meme fratrie. Sem.Hop. Paris 48, 2813–2818 (1972).
  Google Scholar
• Bernues, M. et al. Cytogenetic characterization of a familial papillary renal cell carcinoma. Cancer Genet, and Cytogenet. 84, 123–127 (1995).
  Article CAS Google Scholar
• Melman, K.L. & Rosen, S.W. Lindau's disease: review of the literature and study of a large kindred. Am. J. Med. 36, 595–617 (1964).
  Article Google Scholar
• Cohen, A.J. et al. Hereditary renal-cell carcinoma associated with a chromosomal translocation. NewEngl. J. Med. 301, 592–595 (1979).
  Article CAS Google Scholar
• Kovacs, G. Molecular cytogenetics of renal tumours. Adv. Cancer Res. 62, 89–124 (1993).
  Article CAS Google Scholar
• Latif, F. et al. Identification of the von Hippel-Lindau disease tumour suppressor gene. Science 260, 1317–1320 (1993).
  Article CAS Google Scholar
• Schmidt, L. et al. Mechanism of tumourigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation. Cancer J. from Sci. Am. 1, 191–196 (1995).
  CAS Google Scholar
• Gnarra, J.R. et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet. 7, 85–90 (1994).
  Article CAS Google Scholar
• Herman, J.G. et al. Silencing of the VHL tumour suppressor gene by DNA methylation in renal carcinoma. Proc. Nat. Acad. Sci. USA 91, 9700–9704 (1994).
  Article CAS Google Scholar
• Bergerheim, U.S.R. et al. Chromosomal gains and losses in sporadic and hereditary papillary renal carcinomas by comparative genomic hybridization. J. Urol. 155, 543A(1996).
  Google Scholar
• Cooper, C.S. et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311, 29–33 (1984).
  Article CAS Google Scholar
• Park, M. et al. Mechanism of met oncogene activation. Cell 45, 895–904 (1986).
  Article CAS Google Scholar
• Wainwright, B.J. et al. Isolation of a human gene with protein sequence similarity to human and murine int-1 and the Drosophila segment polarity mutant wingless. EMBO J. 7, 1743–1748 (1988).
  Article CAS Google Scholar
• Nusse, R., SVarmus, H.R. Wnt genes. Cell 69, 1073–1087 (1992).
  Article CAS Google Scholar
• Stuart, E.T. & Gruss, P. PAX: Developmental control genes in cell growth and differentiation. Cell Growth Differ. 7, 405–412 (1996).
  CAS PubMed Google Scholar
• LM.et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458–460 (1993).
• Donis-Keller, H. et al. Mutations in the RET proto-oncogene associated with MEN 2A and FMTC. Hum. Mol. Genet 2, 851–856 (1993).
  Article CAS Google Scholar
• Hofstra, R.M. et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367, 375–376 (1994).
  Article CAS Google Scholar
• Piao, S. & Bernstein, A. A point mutation in the catalytic domain of c-kit induces growth factor independence, tumourigenicity and differentiation of mast cells. Blood 87, 3117–3123 (1996).
  CAS PubMed Google Scholar
• Nagata, H. et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc. Natl. Acad. Sci. USA 92, 10560–10564 (1995).
  Article CAS Google Scholar
• Bolino, A. et al. RET mutations in exons 13 and 14 of FMTC patients. Oncogene 10, 2415–2419 (1995).
  CAS PubMed Google Scholar
• Eng, C. et al. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medulllary thyroid carcinoma and in a family with FMTC. Oncogene 10, 509–513 (1995).
  CAS PubMed Google Scholar
• Santoro, M. et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267, 381–383 (1995).
  Article CAS Google Scholar
• Park, M. et al. Sequence of MET protooncogene cONA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA 84, 6379–6383 (1987).
  Article CAS Google Scholar
• Weidner, K.M., Sachs, M. & Birchmeier, W., Met receptor tyrosine kinase transduces motility, proliferation and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J. Cell Biol. 121, 145–154, (1993).
  Article CAS Google Scholar
• Bladt, F., Riethmacher, D., Isenmann, S., Sguzzi, A. & Birchmeier, C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376, 768–771 (1995).
  Article CAS Google Scholar
• Ponzetto, C. et al. c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene 6, 553–559 (1991).
  CAS PubMed Google Scholar
• Dl Renzo, M. et al. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7, 2549–2553 (1992).
  Google Scholar
• Bremner, R. & Balmain, A. Genetic changes in skin tumour progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61, 407–417 (1990).
  Article CAS Google Scholar
• Wirchubsky, Z., Wiener, F., Spira, J., Sumegi, J. & Klein, G. Triplication of one chromosome no 15 with an altered c-myc homologue in a T-cell lymphoma line of AKR origin (TIKAUT). Int. J. Cancer 33, 477–481 (1984).
  Article Google Scholar
• Bianchi, A.B., Alkaz, C.M. & Conti, C.J. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumours. Proc. Natl. Acad. Sci. USA 87, 6902–6906 (1990).
  Article CAS Google Scholar
• Meloni, A.M., Dobbs, R.M., Pontes, J.E. & Sandberg, A.A. Translocation [X;1] in papillary renal adenocarcinomaA new Cytogenetic subtype. Cancer Genet. Cytogenet. 65, 1–6 (1993).
  Article CAS Google Scholar
• Sidhar, S.K. et al. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol. Genet. 5, 1333–1338 (1996).
  Article CAS Google Scholar
• Weterman, M.A.J., Wilbrink, M. & van Kessel, A.G. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinoma. Proc. Natl. Acad. Sci. USA 93, 15294–15298 (1996).
  Article CAS Google Scholar
• Choyke, P.L. et al. Imaging features of hereditary papillary renal carcinoma. J. Computer Assist. Tomography (in the press).
• Cottingham, R.W. Jr., Idury, R.M. & Schaffer, A.A. Faster sequential genetic linkage computations. Amer. J. Human Genet. 53, 252–263 (1993).
  Google Scholar
• O'Connell, J.R.D.E. The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recording and fuzzy inheritance. Nature Genet. 11, 402–408 (1995).
  Article CAS Google Scholar
• Weier, H.-U.G., Kleine, H.-O. & Gray, J.W. Labeling of the centromeric region on human chromosome 8 by in situ hybridization. Hum. Genet. 87, 489–494 (1991).
  Article CAS Google Scholar
• Takahashi, M., Buma, Y. & Hiai, H. Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence. Oncogene 4, 805–806 (1989).
  CAS Google Scholar